Creative Biolabs, a biotechnology service provider specializing in immuno-oncology research, has announced an upcoming webinar titled "Modeling T Cell Dysfunction in Tumor Microenvironments." The live virtual event is scheduled for September 1, 2026, at 10:00 AM EDT and will feature a keynote presentation by Greg M. Delgoffe, Ph.D., Professor of Immunology at the University of Pittsburgh and Director of the Tumor Microenvironment Center at the UPMC Hillman Cancer Center.
The tumor microenvironment (TME) remains a critical area of study in oncology, as its complexity poses significant challenges for developing effective cancer treatments. The TME is a dynamic ecosystem where cancer cells, immune cells, and various metabolites interact. As tumors progress, they create a metabolically hostile environment characterized by nutrient depletion and the accumulation of immunosuppressive byproducts. These metabolic pressures impair immune cell function, leading to T cell dysfunction, immune evasion, and reduced responses to standard cancer immunotherapies. Understanding these mechanisms is essential for improving therapeutic outcomes.
During the webinar, Dr. Delgoffe will explore innovative approaches to modeling these complex tumor microenvironments. Traditional models often fail to capture the nuanced interactions between tumor metabolism and immune regulation. By utilizing advanced preclinical testing services and robust in vivo and in vitro models, researchers can better replicate these metabolic stress conditions. These advanced systems provide valuable tools to investigate immune suppression and therapeutic responses under physiologically relevant conditions.
"Understanding how metabolic conditions within tumors influence immune-cell behavior is increasingly important in immuno-oncology," said a senior scientific director at Creative Biolabs. "Dr. Delgoffe's work provides an important perspective on how researchers can model these conditions and investigate target discovery and validation."
The webinar will highlight several key topics: how tumor metabolic environments contribute to immune suppression and T cell exhaustion; strategies for modeling TME conditions in preclinical research systems; the mechanisms underlying T cell exhaustion and how nutrient depletion influences T cell function; and how immunometabolism insights can guide therapeutic strategies to enhance cancer immunotherapy. These topics are particularly relevant for cancer immunology researchers, pharmaceutical and biotechnology professionals, and R&D teams dedicated to oncology drug discovery.
This announcement is significant because it addresses a growing need in the oncology field: the ability to accurately model the tumor microenvironment to better predict and improve therapeutic responses. By sharing expertise on advanced modeling techniques, the webinar aims to equip researchers with the knowledge to develop more effective cancer treatments. The event underscores the importance of integrating immunometabolism into preclinical research, which could lead to breakthroughs in overcoming T cell dysfunction and improving immunotherapy outcomes.
For webinar details and registration, interested parties can visit the provided link. Creative Biolabs continues to support immuno-oncology research through its capabilities in antibody discovery and engineering, tumor microenvironment research, immunological assays, and customized preclinical research solutions for pharmaceutical, biotechnology, and academic organizations.
